What one share of Takeda Pharmaceutical Company Limited holds
We are a global R&D-driven biopharmaceutical company focused on discovering and delivering life-transforming treatments in our core therapeutic areas of gastrointestinal and inflammation, neuroscience and oncology, as well as through our plasma-derived therapies and vaccines business.
Takeda Pharmaceutical Company Limited’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2026-03-31; the balance sheet is as of 2026-03-31.
| Sales | $9.51 |
|---|---|
| Profit | −$0.32 |
| Capex (buildings and equipment) | $0.37 |
| Free cash flow | $1.83 |
| Dividends | $0.66 |
| Cash and investments | $1.18 |
| Debt | $9.64 |
| Book value | $14.68 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $10.20 | $0.68 | $0.36 | $1.18 | — | $11.06 |
| 2018 | $10.16 | $1.07 | $0.38 | $1.78 | — | $11.83 |
| 2019 | $9.78 | $0.63 | $0.36 | $1.17 | — | $14.96 |
| 2020 | $9.67 | $0.13 | $0.37 | $1.59 | — | $13.93 |
| 2021 | $9.58 | $1.13 | $0.33 | $2.70 | — | $14.83 |
| 2022 | $10.08 | $0.65 | $0.35 | $2.82 | — | $14.79 |
| 2023 | $9.49 | $0.75 | $0.33 | $1.97 | — | $15.13 |
| 2024 | $9.35 | $0.32 | $0.38 | $1.19 | — | $15.20 |
| 2025 | $9.37 | $0.22 | $0.41 | $1.75 | — | $14.54 |
| 2026 | $9.51 | −$0.32 | $0.37 | $1.83 | — | $14.68 |
Common questions about Takeda Pharmaceutical Company Limited
How much does one share of Takeda Pharmaceutical Company Limited earn?
Over its latest fiscal year, Takeda Pharmaceutical Company Limited lost $0.32 for each share on $9.51 of sales.
Does Takeda Pharmaceutical Company Limited pay a dividend?
Yes. Takeda Pharmaceutical Company Limited paid $0.66 per share in dividends over its latest fiscal year.
What is Takeda Pharmaceutical Company Limited’s book value per share?
Takeda Pharmaceutical Company Limited’s book value is $14.68 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of March 31, 2026.
How much cash and debt does each share of Takeda Pharmaceutical Company Limited have?
Each share of Takeda Pharmaceutical Company Limited has $1.18 of cash and investments and $9.64 of debt, as of March 31, 2026.
What is Takeda Pharmaceutical Company Limited’s free cash flow per share?
$1.83 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.
Has Takeda Pharmaceutical Company Limited bought back shares?
Takeda Pharmaceutical Company Limited’s share count rose about 100% from 2017 to 2026. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.